In cancer, IL‐12‐mediated tumor suppression as well as CCL5‐mediated CD4+ T cell tumor immunity have been revealed.[33, 34] In consistency, our data show increased T cell infiltration after BCG treatment. This evidence concerns the gene CCL5 and cancer.